Jump to content

Pubmed-Letter: Irritable bowel syndrome and antibiotics


Health Reporter

Recommended Posts

Aliment Pharmacol Ther. 2024 Feb;59(3):421. doi: 10.1111/apt.17837.

LINKED CONTENT

This article is linked to Staller et al papers. To view these articles, visit https://doi.org/10.1111/apt.17736 and https://doi.org/10.1111/apt.17839

Editors,

As Staller et al. reported, increased antibiotic dispensing to patients up to 1 year before the diagnosis of irritable bowel syndrome (IBS) could imply alteration of the gut microbiota in the pathogenesis of IBS.1 However, increased healthcare costs include more treatment with many systemic antibiotics after IBS is diagnosed compared with subjects without IBS.2 Since many patients have symptoms for years before they are attributed to IBS, it seems possible that undiagnosed IBS contributed to the findings of Staller et al.

PMID:38197706 | DOI:10.1111/apt.17837

View the full article

Link to comment
Share on other sites

×
×
  • Create New...